Pharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Nivolumab With or Without Tadalafil in Treating Patients With Recurrent Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Conditions:   Lip, Oral Cavity and Pharynx;   Larynx Interventions:   Biological: Nivolumab;   Drug: Tadalafil;   Procedure: Therapeutic Conventional Surgery Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Bristol-Myers Squibb Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2017 Category: Research Source Type: clinical trials